SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]

INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels. This extreme influx of samples quickly exhausted the capacity of existing systems in the Microbiology and Molecular Pathology Department at Sullivan Nicolaides Pathology (SNP) – part of […]